4.2 Article

Factors associated with viral clearance periods from patients with COVID-19: A retrospective observational cohort study

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19

Saskia Trump et al.

Summary: Single-cell analysis reveals the impact of ACEI and ARB treatments on COVID-19 progression in patients with hypertension. ACEI treatment is associated with dampened inflammation and enhanced antiviral responses, while ARB treatment is related to increased epithelial-immune cell interactions, suggesting further investigation is warranted for the clinical benefits of ACEI treatment in this patient population.

NATURE BIOTECHNOLOGY (2021)

Letter Medicine, General & Internal

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Lirong Zou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Pediatrics

A Review of Coronavirus Disease-2019 (COVID-19)

Tanu Singhal

INDIAN JOURNAL OF PEDIATRICS (2020)

Review Infectious Diseases

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Jing Yang et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Article Infectious Diseases

Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan

Kazuya Shirato et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES (2020)

Article Environmental Sciences

Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19

Xiaowen Hu et al.

SCIENCE OF THE TOTAL ENVIRONMENT (2020)

Article Immunology

Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza

Nelson Lee et al.

JOURNAL OF INFECTIOUS DISEASES (2009)